Health
COVID-19: Patients improve after immune-suppressant treatment – Medical Xpress
Most patients hospitalized with COVID-19 (coronavirus) pneumonia experienced improvement after receiving a Food and Drug Administration-approved drug normally given for rheumatoid arthritis, according to an observational study at Cedars-Sinai. Outcomes for pa…
Most patients hospitalized with COVID-19 (coronavirus) pneumonia experienced improvement after receiving a Food and Drug Administration-approved drug normally given for rheumatoid arthritis, according to an observational study at Cedars-Sinai. Outcomes for patients who received the drug, tocilizumab, included reduced inflammation, oxygen requirements, blood pressure support and risk of death, compared with published reports of illness and death associated with severely ill COVID-19 patients.
Th…
-
Noosa News17 hours ago‘Just want to know he’s safe’: Family’s German Shepherd asleep in back of stolen ute
-
Noosa News21 hours agoQueensland Cross-Border Commissioner and former police union boss Ian Leavers found dead at Brisbane home
-
Noosa News24 hours agoDingo hunts shark in shallow waters off K’gari, Queensland
-
Noosa News20 hours agoLogan man Umar Al Enizi cleared of murder after Browns Plains road rage incident in 2021